🔎 Trials Near Me

Pradžia › Nutukimas › Nevada › Las Vegas

Nutukimas klinikiniai tyrimai Las Vegas, NV

27 tyrimai dėl Nutukimas ieško dalyvių vietose Las Vegas ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Renkami dalyviai2 fazė
  • Vector Clinical Trials /ID# 282265, Las Vegas
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-10-02 · NCT07752979

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Renkami dalyviai2 fazė
  • Excel Clinical Research, LLC, Las Vegas
  • Palm Research Center Tenaya, Las Vegas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07783802

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Renkami dalyviai3 fazė
  • Palm Research Center Inc., Las Vegas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07720271

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Renkami dalyviai3 fazė
  • Palm Research Center Tenaya, Las Vegas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Renkami dalyviai3 fazė
  • Excel Clinical Research, Las Vegas
  • Vector Clinical Trials, Las Vegas
Amžius nuo 45 iki 99 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Renkami dalyviai3 fazė
  • AMR Clinical, Las Vegas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT07321886

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Renkami dalyviai2 fazė
  • Las Vegas Medical Research, Las Vegas
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07589608

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

Renkami dalyviai3 fazė
  • AURORA-1 Clinical Site, Las Vegas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-16 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Renkami dalyviai3 fazė
  • AURORA-2 Clinical Site, Las Vegas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-16 · NCT07743450

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Renkami dalyviai3 fazėLaukiami sveiki savanoriai
  • ACCOMPLISH-2 Research Site, Las Vegas
Amžius nuo 18 iki 79 · Visoms lytims · Atnaujinta 2026-09-11 · NCT07654374

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Renkami dalyviai3 fazė
  • Jubilee Clinical Research, Inc., Las Vegas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT07770841

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Renkami dalyviai2 fazė
  • Las Vegas Medical Research, Las Vegas
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-08 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Renkami dalyviai2 fazė
  • Vector Clinical Trials, Las Vegas
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-08 · NCT07215559

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Renkami dalyviai3 fazė
  • Kailera Clinical Site, Las Vegas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-03 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Renkami dalyviai3 fazė
  • Palm Research Center Inc, Las Vegas
  • Vector Clinical Trials, Las Vegas
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-09-03 · NCT07684235

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Renkami dalyviai3 fazė
  • Kailera Clinical Site, Las Vegas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-03 · NCT07284875

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Renkami dalyviai3 fazė
  • Palm Research Center Inc, Las Vegas
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-09-03 · NCT07684144

Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

Renkami dalyviai3 fazė
  • Kailera Clinical Site, Las Vegas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-01 · NCT07284979

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Renkami dalyviai3 fazė
  • Excel Clinical Research, Las Vegas
Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-08-27 · NCT07575399

Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.

Renkami dalyviaiLaukiami sveiki savanoriai
  • University of Nevada, Las Vegas, Las Vegas
Amžius nuo 21 iki 74 · Visoms lytims · Atnaujinta 2026-08-27 · NCT07566325

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Renkami dalyviai3 fazė
  • Research Site, Las Vegas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-25 · NCT07784725

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Renkami dalyviai3 fazė
  • UMC of Southern Nevada, Las Vegas
  • Palm Research Center Inc-Vegas, Las Vegas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-18 · NCT07567001

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Renkami dalyviai3 fazė
  • ACCOMPLISH-1 Research Site, Las Vegas
Amžius nuo 18 iki 79 · Visoms lytims · Atnaujinta 2026-08-10 · NCT07654361

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

Renkami dalyviai2 fazė
  • Palm Research Center, Mountainview Medical Center, Las Vegas
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-07-22 · NCT07477704

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Renkami dalyviai3 fazė
  • Jubilee Clinical Research, Inc., Las Vegas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-09 · NCT07481630

A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets

Renkami dalyviai1 fazė
  • Corxel Investigational site, Las Vegas
Amžius nuo 18 iki 55 · Moterims · Atnaujinta 2026-06-17 · NCT07652047

Nutukimas tyrimai kituose miestuose

Kiti tyrimai Las Vegas

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.